Exercise linked to enhanced brain function in adults at risk for Alzheimer’s Disease
Regular aerobic exercise may decrease the likelihood of developing Alzheimer’s disease, or slow its progression, in adults who are at a higher risk, according to a new study from the University of Wisconsin School of Medicine and Public Health (UW SMPH).
Scoring system predicts seizure risk in hospitalized patients
A new rating system can accurately predict which critically ill patients are in danger of having seizures while hospitalized, a large, multi-national trial shows.
UW–Madison inventors aim to replace old-style breast-surgery marker
Three University of Wisconsin–Madison innovators have invented a better way for surgeons to locate tumors during lumpectomies for breast cancer.
Inflammation predicts response to anti-depression medication
Children and teens with bipolar depression responded better to an antipsychotic medicine if they had increased markers of inflammation in their blood, a new University of Wisconsin–Madison study shows.
Injectable, flexible electrode could replace rigid nerve-stimulating implants
By electrically stimulating nerves, neuromodulation therapies can reduce epileptic seizures, soothe chronic pain, and treat depression and a host of other health conditions without the use of conventional drugs like opioids.
UW study: Adult binge drinking costs Wisconsin $4 billion a year
A new study by the University of Wisconsin Population Health Institute reveals the financial magnitude of adult binge drinking in Wisconsin.
Thomas ‘Rock’ Mackie receives gold medal from radiation oncology society
Cancer research conference focuses on targeted radionuclide therapy
University of Wisconsin-Madison is hosting a national conference on targeted radionuclide therapy (TRT), a promising new technology that combines cytotoxic radioisotopes with molecularly targeted agents to produce an anti-cancer therapy capable of treating local or systemic disease.
Electronic records pin broad set of health risks on genetic premutation
It was long believed the FMR1 premutation — an excessive number of trinucleotide repeats in the FMR1 gene — had no direct effect on the people who carry it. Until recently, the only recognized effect on the carriers of the flawed gene was the risk of having offspring with fragile X syndrome, a rare but serious form of developmental disability.
Study finds major surgery is associated with minor cognitive decline
A new study by researchers at the University of Wisconsin School of Medicine and Public Health has revealed that major surgery is associated with only a minor decline in cognitive ability.
UW launches nation’s first cell therapy trial for kidney transplant patients
For the first time in the United States, a research team will test a personalized cell therapy to treat a common and serious complication facing kidney transplant patients.
Fear of more dangerous second Zika, dengue infections unfounded in monkeys
An initial infection with dengue virus did not prime monkeys for an especially virulent infection of Zika virus, according to a study at the University of Wisconsin–Madison. Nor did a bout with Zika make a follow-on dengue infection more dangerous.